Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Research (NRC) EBT (2016 - 2025)

National Research (NRC) has disclosed EBT for 16 consecutive years, with -$14.6 million as the latest value for Q4 2025.

  • Quarterly EBT fell 264.24% to -$14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Dec 2025, down 100.0% year-over-year, with the annual reading at $32.7 million for FY2024, 18.2% down from the prior year.
  • EBT hit -$14.6 million in Q4 2025 for National Research, down from $6.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $12.6 million in Q3 2021 to a low of -$35.7 million in Q4 2021.
  • Historically, EBT has averaged $5.8 million across 5 years, with a median of $9.2 million in 2023.
  • Biggest five-year swings in EBT: plummeted 461.09% in 2021 and later soared 126.57% in 2022.
  • Year by year, EBT stood at -$35.7 million in 2021, then skyrocketed by 126.57% to $9.5 million in 2022, then grew by 21.07% to $11.5 million in 2023, then decreased by 22.61% to $8.9 million in 2024, then plummeted by 264.24% to -$14.6 million in 2025.
  • Business Quant data shows EBT for NRC at -$14.6 million in Q4 2025, $6.3 million in Q3 2025, and $581000.0 in Q2 2025.